Seattle Genetics | Faida Ya Uendeshaji

Name: Seattle Genetics | Faida Ya Uendeshaji
Creator: TRADING ECONOMICS
License: https://creativecommons.org/licenses/by/4.0/

width

height

	Operating Profit		Tarehe
Abbvie ABBV:US	$ 3753M	498M	2020-12
Amgen AMGN:US	$ 2008M	445M	2020-12
Astellas Pharma 4503:JP	Y 72597M	46539M	2020-12
Bayer BAYN:GR	1.52B	10.91B	2020-12
Biogen BIIB:US	$ -330.6M	1417M	2020-12
Bristol Myers Squibb BMY:US	$ -11831M	13212M	2020-12
Celldex Therapeutics CLDX:US	$ -14.34M	2.98M	2020-09
Daiichi Sankyo 4568:JP	Y 30997M	6654M	2020-12
Eisai 4523:JP	Y 23612M	21653M	2020-12
Eli Lilly And LLY:US	$ 1992.1M	713.8M	2020-12
Esperion Therapeutics ESPR:US	$ -95569000	15.02M	2020-12
Genmab GEN:DC	887M	29M	2020-12
Gilead Sciences GILD:US	$ 2651M	650M	2020-12
Glaxosmithkline GSK:US	$ 1061M	797M	2020-12
GlaxoSmithKline GSK:LN	1.06B	797M	2020-12
Immunogen IMGN:US	$ 36.52M	53.25M	2020-12
Novartis NOVN:VX	2.64B	292M	2020-12
Pfizer PFE:US	$ 524M	1761M	2020-12
Regeneron Pharmaceuticals REGN:US	$ 1167M	113.9M	2020-12
Seattle Genetics SGEN:US	$ 164.99M	473.2M	2020-12
Spectrum Pharmaceuticals SPPI:US	$ -39.57M	3.08M	2020-09
Takeda 4502:JP	Y 143141M	94838M	2020-12
Teva Pharmaceutical TEVA:IT	405M	4.75B	2020-12
Vertex Pharmaceuticals VRTX:US	$ 745.79M	73.55M	2020-12
YTE INCY:US	$ 164.23M	158.9M	2020-12

Seattle Genetics Faida Ya Uendeshaji - Sasa, maadili, data ya kihistoria, utabiri, takwimu, chati na kalenda ya kiuchumi - Mar 2021.